APA (7th ed.) Citation

Calvo-Pinilla, E., Gubbins, S., Mertens, P. P., Ortego, J., & Castillo-Olivares, J. (2018). The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host. Elsevier.

Chicago Style (17th ed.) Citation

Calvo-Pinilla, Eva, Simon Gubbins, Peter P.C Mertens, Javier Ortego, and Javier Castillo-Olivares. The Immunogenicity of Recombinant Vaccines Based on Modified Vaccinia Ankara (MVA) Viruses Expressing African Horse Sickness Virus VP2 Antigens Depends on the Levels of Expressed VP2 Protein Delivered to the Host. Elsevier, 2018.

MLA (9th ed.) Citation

Calvo-Pinilla, Eva, et al. The Immunogenicity of Recombinant Vaccines Based on Modified Vaccinia Ankara (MVA) Viruses Expressing African Horse Sickness Virus VP2 Antigens Depends on the Levels of Expressed VP2 Protein Delivered to the Host. Elsevier, 2018.